| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/11/2007 | EP1307198A4 Protoberberine derivatives which inhibit activity of the mitogen-activated protein kinase |
| 07/11/2007 | EP1303265B1 Use of cox-2 inhibitors as immunostimulants in the treatment of hiv or aids |
| 07/11/2007 | EP1248784B1 Condensed azepines as vasopressin agonists |
| 07/11/2007 | EP1242108B1 Optimized minigenes and peptides encoded thereby |
| 07/11/2007 | EP1237925B1 Mutant er-alpha and test systems for transactivation |
| 07/11/2007 | EP1204414B1 Use of morphinan derivates as medicines |
| 07/11/2007 | EP1177445B1 Methods for screening gaba-modulatory compounds for specified pharmacological activities |
| 07/11/2007 | EP1175398B1 Indoline derivatives as progesterone antagonists |
| 07/11/2007 | EP1154788B1 Inhibitors of separin, method for identifying them and uses |
| 07/11/2007 | EP1140907B1 Triazole compounds with dopamine-d3-receptor affinity |
| 07/11/2007 | EP1135128B1 Novel method of treatment |
| 07/11/2007 | EP1105467B1 USE OF MODIFIED LYSOZYME c TO PREPARE MEDICINAL COMPOSITIONS FOR THE TREATMENT OF SOME SERIOUS DISEASES |
| 07/11/2007 | EP0998291B1 Treatment of diabetes with thiazolidinedione and sulphonylurea |
| 07/11/2007 | EP0975771B1 Type ii tgf-beta receptor/immunoglobulin constant region fusion proteins |
| 07/11/2007 | CN1997629A Novel tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCR's) |
| 07/11/2007 | CN1997628A Thio-substituted biaryl-methanesulfinyl derivatives |
| 07/11/2007 | CN1997371A Nicotinamide derivatives and their use as therapeutic agents |
| 07/11/2007 | CN1997359A Management of ophthalmologic disorders, including macular degeneration |
| 07/11/2007 | CN1995039A Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 07/11/2007 | CN1994462A Anti-fatigue injection of zinc-metallothionein |
| 07/11/2007 | CN1994442A Chinese medicinal composition for preventing and treating radiation enteritis and preparation process thereof |
| 07/11/2007 | CN1994426A Preparation method and quality control method of 'Sheng Mai' soft capsule |
| 07/11/2007 | CN1994420A Blood-clearing face-beautifying health product and preparation method thereof |
| 07/11/2007 | CN1994375A Novel use of sodium salicylate |
| 07/11/2007 | CN1994354A Anti-fatigue medicine prepared by cactus |
| 07/11/2007 | CN1994343A Pharmaceutical composition having functions in activating blood and invigorating qi and preparation process thereof |
| 07/11/2007 | CN1994333A Anti-fatigue medicine prepared from coriolus versicolor mycelium |
| 07/11/2007 | CN1994301A Heterocyclic compounds which are active as inhibitors of beta lactamases |
| 07/11/2007 | CN1994298A Carbamate aspartic acid specific cysteine proteinase inhibitors and uses thereof |
| 07/11/2007 | CN1994289A Application of dibenzocyclootadiene lignans in preparation of tyrosine-inhibiting medicine |
| 07/11/2007 | CN1994151A Functional beverage prepared from sweet potato stem and leaves |
| 07/11/2007 | CN1994109A Preparation method of growth promoting peptide as feed additive |
| 07/11/2007 | CN1325653C Retroviral delivery system |
| 07/11/2007 | CN1325650C Delivery system for porcine somatotropin |
| 07/11/2007 | CN1325645C Histamine and serotonin binding molecules |
| 07/11/2007 | CN1325644C Muteins of human neutrophil gelatinase-associated lipocalin and related proteins |
| 07/11/2007 | CN1325643C Oligonucleotides modulating expression of enzymes involved in synthesis of melanic pigments |
| 07/11/2007 | CN1325637C Ependymal neural stem cells and method for their isolation |
| 07/11/2007 | CN1325501C Heterocyclic compounds |
| 07/11/2007 | CN1325500C Furyl compounds |
| 07/11/2007 | CN1325499C Thienyl compounds |
| 07/11/2007 | CN1325498C Novel crystalline compound |
| 07/11/2007 | CN1325497C Pharmaceutically active isoindoline derivs. |
| 07/11/2007 | CN1325493C Aza-bicycloalkyl ethers and their use as alpha7-nachr agonist |
| 07/11/2007 | CN1325491C Novel crystals |
| 07/11/2007 | CN1325482C Biscyanophenylmethyl-triazole for use in prevention of breast cancer |
| 07/11/2007 | CN1325480C Novel phenylalanine derivatives |
| 07/11/2007 | CN1325479C Pyrimidine compounds |
| 07/11/2007 | CN1325476C Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, noval compounds thereof and their use as chemotherapeutic agents |
| 07/11/2007 | CN1325473C Novel azasugar derivative and drug containing the same as the active ingredient |
| 07/11/2007 | CN1325118C Ion composite type water-soluble pharmaceutical compositions, and use thereof |
| 07/11/2007 | CN1325107C Composition for treating bee disease and medicinal fodder |
| 07/11/2007 | CN1325084C Medicated wine for treating senile disease and its prepn process |
| 07/11/2007 | CN1325053C Controlled-release drug composition |
| 07/11/2007 | CN1325049C Composition containing epigallocatechin gallate |
| 07/11/2007 | CN1324977C Health-care soft sweets of Chinese herbal medicine and its manufacturing method |
| 07/10/2007 | US7241900 Synthesis of indole thiazole compounds as ligands for the Ah receptor |
| 07/10/2007 | US7241890 Heat shock protein 90 inhibitors; breast cancer, melanomas; inflammation, infectious diseases, autoimmune disorders, ischemia |
| 07/10/2007 | US7241882 Polyamide nucleic acid derivatives, and agents, and processes for preparing them |
| 07/10/2007 | US7241814 Preparation of metallic nanoparticles with shell-crosslinked micelle as mold |
| 07/10/2007 | US7241796 Peptidomimetic compounds |
| 07/10/2007 | US7241793 For therapy of cardiovascular diseases |
| 07/10/2007 | US7241789 Substituted indoles and their use as integrin antagonists |
| 07/10/2007 | US7241785 Five-membered heterocyclic alkanoic acid derivative |
| 07/10/2007 | US7241783 Using a thiosemicarbazone |
| 07/10/2007 | US7241781 Thiazolyl inhibitors of Tec family tyrosine kinases |
| 07/10/2007 | US7241778 E.g., 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-piperidine and 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-azepane; these compounds modulate the activity of the histamine receptor, specifically the H3 receptor, without the inherent problems associated with the presence of an imidazolyl moiety |
| 07/10/2007 | US7241777 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors |
| 07/10/2007 | US7241765 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 07/10/2007 | US7241762 Administering racemic reboxetine or a salt thereof for inhibition of norepinephrine reuptake |
| 07/10/2007 | US7241757 Amidino derivatives and their use as thrombin inhibitors |
| 07/10/2007 | US7241755 E.g., pentamethyl-16-[1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-1-aza-13(Z)-cyclohexadecene-2,6-dione and 4S-[4R*,7S*,8R*,9R*,15R*(E)]]-4,8-dihydroxy-5,5,7,9,13,16-hexamethyl-16-[1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-1-oxa-13-cyclohexadecene-2,6-dione; antiproliferative agents |
| 07/10/2007 | US7241739 Contacting Bone Morphogenic Protein with human Cerberus protein to antagonize the function of a Bone Moarphogenic Protein or induce neural development |
| 07/10/2007 | US7241738 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/10/2007 | US7241737 Urotensin-II agonists and antagonists |
| 07/10/2007 | US7241733 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses |
| 07/10/2007 | US7241591 Adenovirus comprising a gene coding for glutathione peroxidase |
| 07/10/2007 | US7241576 Applications of a novel cytokine, named THANK, for TNF homologue that activates apoptosis, NF- kappa B and c-jun N-terminal kinase. Such applications include using THANK inhibitors to inhibit the activation of NF-kappa B and to |
| 07/10/2007 | US7241571 Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis |
| 07/10/2007 | US7241445 Human monoclonal antibody against hepatitis C virus E2 glycoprotein |
| 07/10/2007 | CA2441461C Topical formulations for the transdermal delivery of niacin and methods of treating hyperlipidemia |
| 07/10/2007 | CA2421910C Xanthine phosphodiesterase v inhibitors |
| 07/10/2007 | CA2396814C Novel 1,3-dihydro-2h-indol-2-one derivatives, preparation method and pharmaceutical compositions containing them |
| 07/10/2007 | CA2380072C Nicotine in therapeutic angiogenesis and vasculogenesis |
| 07/10/2007 | CA2378628C New indenoindolone derivatives, the process for preparing them and the pharmaceutical compounds that contain them |
| 07/10/2007 | CA2194462C Hard tissue stimulating agent |
| 07/10/2007 | CA2190807C Acetylsalicylic acid and tocopherol stable pharmaceutical composition |
| 07/10/2007 | CA2135710C Melatonin derivatives for use in treating desynchronization disorders |
| 07/10/2007 | CA2064604C Method for inhibiting pulmonary oxygen toxicity |
| 07/05/2007 | WO2007074940A1 P2x4 receptor antagonist |
| 07/05/2007 | WO2007074910A1 Controlled release solid preparation |
| 07/05/2007 | WO2007074859A1 Anti-c-mannosylated peptide antibody and use thereof |
| 07/05/2007 | WO2007074291A2 Incontinence treatment methods |
| 07/05/2007 | WO2007047880A3 Compositions for lowering serum cholesterol and/or triglycerides |
| 07/05/2007 | WO2007023495A3 Method for production of single- and multi-layer microcapsules |
| 07/05/2007 | WO2007008566A3 Inorganic shell-based radionuclide nanoparticles bound to biomolecules |
| 07/05/2007 | US20070155970 Process for the manufacture of hmg-coa reductase inhibitory mevalonic acid derivatives |
| 07/05/2007 | US20070155959 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 07/05/2007 | US20070155808 G Protein-Coupled Receptors (GPR40); insulin secretagogue; diabetes; 3-[4-[[4-[[(2-Phenylethyl)(4-phenyl-1,3-thiazol-2-yl)amino]methyl]benzyl]oxy]phenyl]propanoic acid |
| 07/05/2007 | US20070155801 Advanced glycation end-product intermediaries and post-amadori inhibition |